First Time Loading...

Coloplast A/S
OTC:CLPBF

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
OTC:CLPBF
Watchlist
Price: 121.99 USD -4.84% Market Closed
Updated: May 18, 2024

EV/EBITDA
Enterprise Value to EBITDA

25.9
Current
25.6
Median
13.1
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
25.9
=
Enterprise Value
207.6B
/
EBITDA
8B
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
23.3
2-Years Forward
EV/EBITDA
20.8
3-Years Forward
EV/EBITDA
18.8

See Also

Discover More